Tuberculosis Elimination and Laboratory Cooperative Agreements

Post Date

June 30th 2009

Application Due Date

August 28th 2009

Funding Opportunity Number

CDC-RFA-PS10-1005

CFDA Number(s)

93.116

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

136

Eligibility Categories

Other

Eligible applicants that can apply for this funding opportunity are listed below: •State and territorial governments (includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) or their Bona Fide Agents •Political subdivisions of States (includes the cities of Chicago, Houston, Los Angeles, New York City, Philadelphia, San Diego, San Francisco, Detroit, and Baltimore) or their Bona Fide Agents, and in consultation with their state government)

Funding

• Estimated Total Funding:

  $92300000

• Award Range:

  $1522399 - $10450782

Grant Description

CDC’s Procurement and Grants Office has published a funding opportunity announcement entitled, “Tuberculosis Elimination and Laboratory Cooperative Agreements.” Approximately $ 92.3 million will be available in fiscal year 2010 to fund 136 awards. The purpose of this FOA is to assist the current efforts of state, local, and territorial TB programs to prevent, control, and eventually eliminate TB in the United States. For complete program details, please see the full announcement on the Grants.gov website at www.grants.gov. The estimated funding date is January 1, 2010.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  PGOTIMS
  Phone 770-488-2700

• Agency Mailing Address:

  Technical Information Management Section

• Agency Email Address:

  pgotim@cdc.gov

• More Information:

  Link to the Full Announcement can be found at the top of this page.